Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic Perspective

Author： Boden William   Flather Marcus   Bhatt Deepak  

Publisher： Springer Publishing Company

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.24, Iss.3, 2010-06, pp. : 207-216

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease and Established Azathioprine Therapy

By L.P.L. Gilissen  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 479-486

Adis International

Access to resources Recommend Favorite

Dual antiplatelet therapy: no added benefits for high-risk patients

By  

Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Antiplatelet Agents in the Prevention of Cardiovascular Morbidity and Mortality in Older Patients With Vascular Disease

By Aronow W.S.  

Drugs & Aging, Vol. 15, Iss. 2, 1999-08 ,pp. : 91-101

Adis International

Access to resources Recommend Favorite

Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5273-5293

Bentham Science Publishers

Access to resources Recommend Favorite

Stent Thrombosis and Duration of Dual Antiplatelet Therapy

By  

Current Pharmaceutical Design, Vol. 16, Iss. 36, 2010-12 ,pp. : 4052-4063

Bentham Science Publishers

Access to resources Recommend Favorite